logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
September 28, 2021
美國要聞

CDC發第三劑副作用報告 與第二劑類似

疾病管制與預防中心CDC 週二(28日)發布一份最新有關第三針補強針報告。報告指出,補強針的副作用與第二劑相似,沒有出現新的、嚴重症狀。CDC主任瓦倫斯基表示,這證明加強劑耐受性良好。

瓦倫斯基表示,第三劑部作用大多是輕度中度的,與第二季相似,並且狀況是短暫的。

報告發現,接種第三劑輝瑞或莫德納新冠疫苗的人中,有79.4%報告局部副作用反應,如注射部位疼痛,而第二劑此一比率為77.6%。

此外,74.1%的人報告第三劑注射後有全身性反應,例如頭疼或疲勞,而第二劑注射後比率為76.5%。

CDC報告表示,這些初步結果發現,在額外接種一劑疫苗後,沒有意外的不良反應。

白宮防疫顧問佛奇(Anthony Fauci)27日也指出:「隨著獲得越來越多數據,當前兩劑打完mRNA疫苗後,追加劑或第三劑最終會變成,我們使用的標準方案。」

分享:

SHARE THIS ARTICLE

by sukie
0
0
Related Posts
第三劑打半劑 FDA預計將批准莫德納加強針減半施打
September 29, 2021
美國要聞
美軍最後一架班機撤離阿富汗 塔利班慶祝完全獨立
August 31, 2021
美國要聞
拜登:將不會延長這永無止盡的戰爭
August 31, 2021
美國要聞
北韓試射短程彈道飛彈 美:無立即性威脅
Previous post 北韓試射短程彈道飛彈 美:無立即性威脅
Next post 岸田文雄當選自民黨總裁 將任日本新首相
岸田文雄當選自民黨總裁 將任日本新首相

即時新聞

巴西前總統博索納羅被下令戴電子腳鐐

July 18, 2025

加薩天主教教堂遭砲擊致三死 教會領袖出訪

July 18, 2025

曼哈頓兩條巴士路線配備攝像頭 處罰違規駕駛者

July 18, 2025

紐約市府擴大試點計畫 解決住宅區犯罪問題

July 18, 2025

洛杉磯執法培訓中心發生爆炸 三名警員死亡

July 18, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy